Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...

Rating for Alcon jumped into a new percentile Tuesday, as it got a lift from 70 to 73. Please watch the video at ...

Investing.com -- Alcon (SIX: ALCC) has received an upgrade to a "buy" rating from BofA Securities in a note dated Tuesday, signaling the beginning of an earnings growth cycle for the Swiss eye care ...

Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Alcon (ALC – Research Report) today and set a price target of $100.00. The ...

Alcon announced today that it entered into a definitive merger agreement through which it intends to acquire Lensar.

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology ...

In a welcome move, Alcon saw its Relative Strength Rating rise from 68 to 71 on Tuesday. Please watch the video at Investors.com - How To Buy Stocks: Do You Know Your Stock's Personality Type? IBD's ...

Low bond yields and interest rates are often credited with supporting higher prices in the stock market. That's because lower bond yields can make the potentially higher yields offered by stocks ...

Infosys is contributing 55.9 points to the downside Axis Bank is contributing 17.8 points to the downside Kotak Mahindra Bank is contributing 15.7 points to the index upside HDFC Bank is contributing ...

Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

Tariffs are widely expected to raise prices for consumers, since importers typically pass along a share of the added cost to shoppers. The stock market has plunged since Trump imposed tariffs on ...